Tissue-Specific Expression and Regulation of Sexually Dimorphic Genes in Mice
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice
Loyola University Chicago Loyola eCommons Biology: Faculty Publications and Other Works Faculty Publications 2013 Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice Mihaela Palicev Gunter P. Wagner James P. Noonan Benedikt Hallgrimsson James M. Cheverud Loyola University Chicago, [email protected] Follow this and additional works at: https://ecommons.luc.edu/biology_facpubs Part of the Biology Commons Recommended Citation Palicev, M, GP Wagner, JP Noonan, B Hallgrimsson, and JM Cheverud. "Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice." Genome Biology and Evolution 5(10), 2013. This Article is brought to you for free and open access by the Faculty Publications at Loyola eCommons. It has been accepted for inclusion in Biology: Faculty Publications and Other Works by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. © Palicev et al., 2013. GBE Genomic Correlates of Relationship QTL Involved in Fore- versus Hind Limb Divergence in Mice Mihaela Pavlicev1,2,*, Gu¨ nter P. Wagner3, James P. Noonan4, Benedikt Hallgrı´msson5,and James M. Cheverud6 1Konrad Lorenz Institute for Evolution and Cognition Research, Altenberg, Austria 2Department of Pediatrics, Cincinnati Children‘s Hospital Medical Center, Cincinnati, Ohio 3Yale Systems Biology Institute and Department of Ecology and Evolutionary Biology, Yale University 4Department of Genetics, Yale University School of Medicine 5Department of Cell Biology and Anatomy, The McCaig Institute for Bone and Joint Health and the Alberta Children’s Hospital Research Institute for Child and Maternal Health, University of Calgary, Calgary, Canada 6Department of Anatomy and Neurobiology, Washington University *Corresponding author: E-mail: [email protected]. -
Variation in the Anopheles Gambiae TEP1 Gene Shapes Local Population Structures of Malaria Mosquitoes
Variation in the Anopheles gambiae TEP1 Gene Shapes Local Population Structures of Malaria Mosquitoes D i s s e r t a t i o n Zur Erlangung des akademischen Grades D o c t o r r e r u m n a t u r a l i u m (Dr. rer. nat.) Im Fach Biologie eingereicht an der Lebenswissenschaftlichen Fakultät der Humboldt-Universität zu Berlin von BSc. (Biochemistry and Molecular Biology), MSc. (Biochemistry) Evans Kiplangat Rono Präsidentin der Humboldt-Universität zu Berlin: Prof. Dr.-Ιng. Dr. Sabine Kunst Dekan der Lebenswissenschaftlichen Fakultät: Prof. Dr. Bernhard Grimm Gutachter/innen: 1. Dr. Elena A. Levashina 2. Prof. Dr. Arturo Zychlinski 3. Prof. Dr. Susanne Hartmann Eingereicht am: Donnerstag, 04.05.2017 Tag der mündlichen Prüfung: Donnerstag, 29.06.2017 ii Zusammenfassung Abstract Zusammenfassung Rund eine halbe Million Menschen sterben jährlich im subsaharischen Afrika an Malaria Infektionen, die von der Anopheles gambiae Mücke übertragen werden. Die Allele (*R1, *R2, *S1 und *S2) des A. gambiae complement-like thioester-containing Protein 1 (TEP1) bestimmen die Fitness der Mücken, welches die männlichen Fertilität und den Resistenzgrad der Mücke gegen Pathogene wie Bakterien und Malaria- Parasiten. Dieser Kompromiss zwischen Reproduktion und Immunnität hat Auswirkungen auf die Größe der Mückenpopulationen und die Rate der Malariaübertragung, wodurch der TEP1 Lokus ein Primärziel für neue Malariakontrollstrategien darstellt. Wie die genetische Diversität von TEP1 die genetische Struktur natürlicher Vektorpopulationen beeinflusst, ist noch unklar. Die Zielsetzung dieser Doktorarbeit waren: i) die biogeographische Kartographierung der TEP1 Allele und Genotypen in lokalen Malariavektorpopulationen in Mali, Burkina Faso, Kamerun, und Kenia, und ii) die Bemessung des Einflusses von TEP1 Polymorphismen auf die Entwicklung humaner P. -
Mouse Tep1 Conditional Knockout Project (CRISPR/Cas9)
https://www.alphaknockout.com Mouse Tep1 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Tep1 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Tep1 gene (NCBI Reference Sequence: NM_009351 ; Ensembl: ENSMUSG00000006281 ) is located on Mouse chromosome 14. 55 exons are identified, with the ATG start codon in exon 2 and the TGA stop codon in exon 55 (Transcript: ENSMUST00000006444). Exon 10 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Tep1 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-321A24 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a disruption in this gene show no obvious phenotype. No changes are seen in telomerase activity or telomere length. Exon 10 starts from about 19.88% of the coding region. The knockout of Exon 10 will result in frameshift of the gene. The size of intron 9 for 5'-loxP site insertion: 4878 bp, and the size of intron 10 for 3'-loxP site insertion: 990 bp. The size of effective cKO region: ~610 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 10 11 12 13 55 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Tep1 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. -
Handbook for Parents
Contributors Cassandra L. Aspinall, MSW, LICSW Christine Feick, MSW Craniofacial Center, Seattle Children’s Hospital; Ann Arbor, MI University of Washington School of Social Work, Seattle, WA Sallie Foley, LMSW Certified Sex Therapist, AASECT; Dept. Social Arlene B. Baratz, MD Work/Sexual Health, University of Michigan Medical Advisor, Androgen Insensitivity Health Systems, Ann Arbor, MI Syndrome Support Group, Pittsburgh, PA Joel Frader, MD, MA Max & Tamara Beck General Academic Pediatrics, Children’s Atlanta, GA Memorial Hospital; Dept. Pediatrics and Program in Medical Humanities & Bioethics, William Byne, MD Feinberg School of Medicine, Northwestern Psychiatry, Mount Sinai Medical Center, New University, Chicago, IL York, NY Jane Goto David Cameron Board of Directors, Intersex Society of North Intersex Society of North America, San America; Board of Directors, Androgen Francisco, CA Insensitivity Syndrome Support Group, Seattle, Anita J. Catlin, DSNc, FNP, FAAN WA Nursing and Ethics, Sonoma State University, Michael Grant Sonoma, CA Lansing, MI Cheryl Chase Janet Green Founder and Executive Director, Intersex Society Co-Founder, Bodies Like Ours; Board of of North America, Rohnert Park, CA Directors, CARES Foundation; Board of Kimberly Chu, LCSW, DCSW Overseers, Beth Israel Hospital; Board of Department of Child & Adolescent Psychiatry, Trustees, Continuum Healthcare, New York, Mount Sinai Medical Center, New York, NY NY Howard Devore Philip A. Gruppuso, MD San Francisco, CA Associate Dean of Medical Education, Brown University; Pediatric Endocrinology, Rhode Alice Dreger, Ph.D. (Project Coordinator and Island Hospital, Providence, RI Editor) Program in Medical Humanities and Bioethics, William G. Hanley, BPS Feinberg School of Medicine, Northwestern Memphis, TN University, Chicago, IL iii iv Debora Rode Hartman Charmian A. -
Telomere Shortening and Apoptosis in Telomerase-Inhibited Human Tumor Cells
Downloaded from genesdev.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Telomere shortening and apoptosis in telomerase-inhibited human tumor cells Xiaoling Zhang,1 Vernon Mar,1 Wen Zhou,1 Lea Harrington,2 and Murray O. Robinson1,3 1Department of Cancer Biology, Amgen, Thousand Oaks, California 91320 USA; 2Amgen Institute/Ontario Cancer Institute, Toronto, Ontario M5G2C1 Canada Despite a strong correlation between telomerase activity and malignancy, the outcome of telomerase inhibition in human tumor cells has not been examined. Here, we have addressed the role of telomerase activity in the proliferation of human tumor and immortal cells by inhibiting TERT function. Inducible dominant-negative mutants of hTERT dramatically reduced the level of endogenous telomerase activity in tumor cell lines. Clones with short telomeres continued to divide, then exhibited an increase in abnormal mitoses followed by massive apoptosis leading to the loss of the entire population. This cell death was telomere-length dependent, as cells with long telomeres were viable but exhibited telomere shortening at a rate similar to that of mortal cells. It appears that telomerase inhibition in cells with short telomeres lead to chromosomal damage, which in turn trigger apoptotic cell death. These results provide the first direct evidence that telomerase is required for the maintenance of human tumor and immortal cell viability, and suggest that tumors with short telomeres may be effectively and rapidly killed following telomerase inhibition. [Key Words: TERT; telomere; dominant negative; proliferation; cancer] Received June 4, 1999; revised version accepted August 3, 1999. The termini of most eukaryotic chromosomes are com- TEP1 binds the telomerase RNA and associates with posed of terminal repeats called telomeres. -
Genetics, Underlying Pathologies and Psychosexual Differentiation Valerie A
REVIEWS DSDs: genetics, underlying pathologies and psychosexual differentiation Valerie A. Arboleda, David E. Sandberg and Eric Vilain Abstract | Mammalian sex determination is the unique process whereby a single organ, the bipotential gonad, undergoes a developmental switch that promotes its differentiation into either a testis or an ovary. Disruptions of this complex genetic process during human development can manifest as disorders of sex development (DSDs). Sex development can be divided into two distinct processes: sex determination, in which the bipotential gonads form either testes or ovaries, and sex differentiation, in which the fully formed testes or ovaries secrete local and hormonal factors to drive differentiation of internal and external genitals, as well as extragonadal tissues such as the brain. DSDs can arise from a number of genetic lesions, which manifest as a spectrum of gonadal (gonadal dysgenesis to ovotestis) and genital (mild hypospadias or clitoromegaly to ambiguous genitalia) phenotypes. The physical attributes and medical implications associated with DSDs confront families of affected newborns with decisions, such as gender of rearing or genital surgery, and additional concerns, such as uncertainty over the child’s psychosexual development and personal wishes later in life. In this Review, we discuss the underlying genetics of human sex determination and focus on emerging data, genetic classification of DSDs and other considerations that surround gender development and identity in individuals with DSDs. Arboleda, V. A. et al. Nat. Rev. Endocrinol. advance online publication 5 August 2014; doi:10.1038/nrendo.2014.130 Introduction Sex development is a critical component of mammalian disrupted, which occurs primarily as a result of genetic development that provides a robust mechanism for con- mutations that interfere with either the development of tinued generation of genetic diversity within a species. -
Tetrahymena Proteins P80 and P95 Are Not Core Telomerase Components
Tetrahymena proteins p80 and p95 are not core telomerase components Douglas X. Mason*†, Chantal Autexier†‡, and Carol W. Greider*†§ *Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205; and †Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 Communicated by Thomas J. Kelly, The Johns Hopkins University, Baltimore, MD, August 29, 2001 (received for review July 3, 2001) Telomeres provide stability to eukaryotic chromosomes and consist activity is still present in cells that lack these genes (34). EST1 of tandem DNA repeat sequences. Telomeric repeats are synthe- and EST3 physically interact with telomerase and telomerase sized and maintained by a specialized reverse transcriptase, termed RNA, indicating they are telomerase-associated proteins (33). In telomerase. Tetrahymena thermophila telomerase contains two human cells, telomerase-associated protein 1 (TEP1) and the essential components: Tetrahymena telomerase reverse transcrip- chaperone proteins hsp90 and p23 were found to interact with tase (tTERT), the catalytic protein component, and telomerase RNA the hTERT protein and telomerase activity (35, 36). The pro- that provides the template for telomere repeat synthesis. In addi- teins L22, hStau, and dyskerin bind human telomerase RNA and tion to these two components, two proteins, p80 and p95, were are associated with telomerase activity in cell extracts (37, 38). previously found to copurify with telomerase activity and to In the ciliate E. audiculatus, the protein p43 was identified by interact with tTERT and telomerase RNA. To investigate the role of copurification with TERT and telomerase activity (39). p43 is p80 and p95 in the telomerase enzyme, we tested the interaction physically associated with telomerase activity in cell extracts and of p80, p95, and tTERT in several different recombinant expression is a homologue of the human La protein (40). -
Lessons Learned on Data Sharing in COVID-19 Pandemic Can Inform Future Outbreak Preparedness and Response” Science & Diplomacy, Vol
Jonathan LoTempio, D’Andre Spencer, Rebecca Yarvitz, Arthur Delot Vilain, Eric Vilain, and Emmanuèle Délot, “We Can Do Better: Lessons Learned on Data Sharing in COVID-19 Pandemic Can Inform Future Outbreak Preparedness and Response” Science & Diplomacy, Vol. 9, No. 2 (June 2020). https://www.sciencediplomacy.org/article/2020/we-can-do-better- lessons-learned-data-sharing-in-covid-19-pandemic-can-inform-future This copy is for non-commercial use only. More articles, perspectives, editorials, and letters can be found at www.sciencediplomacy.org. Science & Diplomacy is published by the Center for Science Diplomacy of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society. We Can Do Better: Lessons Learned on Data Sharing in COVID-19 Pandemic Can Inform Future Outbreak Preparedness and Response Jonathan LoTempio, D’Andre Spencer, Rebecca Yarvitz, Arthur Delot Vilain, Eric Vilain, and Emmanuèle Délot he COVID-19 pandemic will remain a critical issue until a safe and Teffective vaccine is in global use. A strong international network exists for the systematic collection and sharing of influenza genome sequence data, which has proven extensible to COVID-19.¹ However, the robust demographic and clinical data needed to understand the progression of COVID-19 within individuals and across populations are collected by an array of local, regional, federal, and/or national agencies, with country-specific, often overlapping mandates. The networks tasked with transmitting descriptive, disaggregated data have not done so in a standardized manner; most data are made available in variable, incompatible forms, and there is no central, global hub. -
Telomere Length Regulation in Mice Is Linked to a Novel Chromosome Locus
Proc. Natl. Acad. Sci. USA Vol. 95, pp. 8648–8653, July 1998 Cell Biology Telomere length regulation in mice is linked to a novel chromosome locus LINGXIANG ZHU*†,KAREN S. HATHCOCK*‡§,PRAKASH HANDE¶,PETER M. LANSDORP¶,MICHAEL F. SELDIN†, i AND RICHARD J. HODES‡ †Rowe Program in Genetics, Departments of Biological Chemistry and Medicine University of California, Davis, Davis, CA 95616; ‡Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; ¶Terry Fox Laboratory for HematologyyOncology, British Columbia Cancer Research Center, 601 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada; and iNational Institute on Aging, National Institutes of Health, Bethesda, MD 20892 Edited by Irving L. Weissman, Stanford University School of Medicine, Stanford, CA, and approved, May 20, 1998 (received for review September 15, 1997) ABSTRACT Little is known about the mechanisms that housed in the animal facility at PerImmune, Rockville, MD or regulate species-specific telomere length, particularly in mam- Bioqual, Rockville, MD. malian species. The genetic regulation of telomere length was Telomere Length Analysis. Single cell suspensions of spleen therefore investigated by using two inter-fertile species of were generated by conventional methods. Single cell suspen- mice, which differ in their telomere length. Mus musculus sions of liver were generated by incubating minced livers with (telomere length >25 kb) and Mus spretus (telomere length collagenase, type IV, (2 mgyml; Sigma) for 30 min at 37°C. 5–15 kb) were used to generate F1 crosses and reciprocal After depleting red blood cells, cell suspensions were mixed backcrosses, which were then analyzed for regulation of with an equal volume of 1.2% Incert Agarose (FMC) to make telomere length. -
Genetic Variants in the TEP1 Gene Are Associated with Prostate Cancer Risk and Recurrence
Prostate Cancer and Prostatic Diseases (2015) 18, 310–316 © 2015 Macmillan Publishers Limited All rights reserved 1365-7852/15 www.nature.com/pcan ORIGINAL ARTICLE Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence CGu1,2,8,QLi2,3,4,8, Y Zhu1,2,8,YQu1,2, G Zhang1,2, M Wang2,3, Y Yang5,6, J Wang5,6, L Jin5,6,QWei3,7 and D Ye1,2 BACKGROUND: Telomere-related genes play an important role in carcinogenesis and progression of prostate cancer (PCa). It is not fully understood whether genetic variations in telomere-related genes are associated with development and progression in PCa patients. METHODS: Six potentially functional single-nucleotide polymorphisms (SNPs) of three key telomere-related genes were evaluated in 1015 PCa cases and 1052 cancer-free controls, to test their associations with risk of PCa. Among 426 PCa patients who underwent radical prostatectomy (RP), the prognostic significance of the studied SNPs on biochemical recurrence (BCR) was also assessed using the Kaplan–Meier analysis and Cox proportional hazards regression model. The relative telomere lengths (RTLs) were measured in peripheral blood leukocytes using real-time PCR in the RP patients. RESULTS: TEP1 rs1760904 AG/AA genotypes were significantly associated with a decreased risk of PCa (odds ratio (OR): 0.77, 95% confidence interval (CI): 0.64–0.93, P = 0.005) compared with the GG genotype. By using median RTL as a cutoff level, RP patients with TEP1 rs1760904 AG/AA genotypes tended to have a longer RTL than those with the GG genotype (OR: 1.55, 95% CI: 1.04–2.30, P = 0.031). -
Worldwide Genetic Structure in 37 Genes Important in Telomere Biology
Heredity (2012) 108, 124–133 & 2012 Macmillan Publishers Limited All rights reserved 0018-067X/12 www.nature.com/hdy ORIGINAL ARTICLE Worldwide genetic structure in 37 genes important in telomere biology L Mirabello1, M Yeager2, S Chowdhury2,LQi2, X Deng2, Z Wang2, A Hutchinson2 and SA Savage1 1Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA and 2Core Genotyping Facility, National Cancer Institute, Division of Cancer Epidemiology and Genetics, SAIC-Frederick, Inc., NCI-Frederick, Frederick, MD, USA Telomeres form the ends of eukaryotic chromosomes and and differentiation were significantly lower in telomere are vital in maintaining genetic integrity. Telomere dysfunc- biology genes compared with the innate immunity genes. tion is associated with cancer and several chronic diseases. There was evidence of evolutionary selection in ACD, Patterns of genetic variation across individuals can provide TERF2IP, NOLA2, POT1 and TNKS in this data set, which keys to further understanding the evolutionary history of was consistent in HapMap 3. TERT had higher than genes. We investigated patterns of differentiation and expected levels of haplotype diversity, likely attributable to population structure of 37 telomere maintenance genes a lack of linkage disequilibrium, and a potential cancer- among 53 worldwide populations. Data from 898 unrelated associated SNP in this gene, rs2736100, varied substantially individuals were obtained from the genome-wide scan of the in genotype frequency across major continental regions. It is Human Genome Diversity Panel (HGDP) and from 270 possible that the genes under selection could influence unrelated individuals from the International HapMap Project telomere biology diseases. -
Predicted Binding Sites for the Regulatory Small Vault Rnas on Messenger Rnas
Predicted Binding Sites for the Regulatory Small Vault RNAs on Messenger RNAs of Selected Genes Relating to Cancer, Multi-drug Resistance, and Inflammation Craig Jackson Predicted Binding Sites for the Regulatory Small Vault RNAs on Messenger RNAs of Selected Genes Relating to Cancer, Multi-drug Resistance, and Inflammation An Honors Thesis (HONRS 499) By Craig Jackson Thesis Advisor Dr. Carolyn Vann Ball State University Muncie, Indiana May 2010 Expected Date of Graduation May 2010 · r ~ J I LA ndcr or l"',cT, --h~: I 1. -r~ ;"t.I-;?v 2 Jj Abstract .Q '0 Vaults are large ribonucleoprotein particles believed to be involved in multidrug resistance and intracellular transport. The vault complex consists of three proteins and non-coding vault RNAs. It has been shown that the non-coding vault RNA encodes regulatory small vault RNAs (svRNAs). These svRNAs associate with the RNA-induced silencing complex and regulate gene expression similarly to microRNAs. It is unknown which genes the svRNAs regulate, but they are thought to regulate genes relating to multidrug resistance and intracellular antigen transport. I have selected several genes of interest relating to cancer, multidrug resistance, inflammation, and the autoimmune response to predict whether the svRNAs regulate these genes. Since the svRNAs regulate genes similarly to microRNA, I used microRNA target prediction tools to find potential functional binding sites for the svRNAs in the 3' untranslated regions of the selected gene messenger RNAs. I found several target sites that have a very high potential to be functional binding sites for the svRNAs. These results can be used to conduct experiments to verify that the svRNAs bind to the predicted target sites and regulate the expression of the targeted gene.